Dallas TX – Sept. 24, 2026 – PetVivo Holdings, Inc. (OTCQX: PETV) has appointed Jaime K. Pickett, DVM, MBA, and Michael K. Handley to its Board of Directors, adding experience in veterinary care and life sciences commercialization as the company works to expand adoption of its biomedical products.
PetVivo develops, manufactures and commercializes medical devices, biomaterials and therapeutics for animal health, with potential applications in human medicine. Its lead commercial product, SPRYNG® with OsteoCushion® technology, is a veterinarian-administered joint injection for managing lameness and other joint-related conditions, including osteoarthritis, in dogs, cats and horses.
Alongside PetVivo Holdings, Inc. (OTCQX: PETV), investors are watching several low-priced healthcare and technology stocks: BullFrog AI (NASDAQ: BFRG), Peraso Inc. (NASDAQ: PRSO), Vistagen (NASDAQ: VTGN), VivoSim Labs, Inc. (NASDAQ: VIVS), Healthcare Triangle, Inc. (NASDAQ: HCTI), IGC Pharma (NYSE: IGC) and Endovia Health (NYSE: EDVA) moving aggressively now.
Dr. Pickett brings more than 20 years of experience in veterinary care, animal-health operations and product commercialization. Her perspective as a veterinarian could help PetVivo strengthen its relationships with veterinary practices and support broader product adoption.
Handley brings more than 25 years of experience across biotechnology, pharmaceuticals and medical devices, including work in capital raising, product launches, licensing and strategic transactions. His appointment adds expertise relevant to PetVivo’s commercialization and growth plans.
Both appointments became effective Sept. 22. Pickett and Handley fill vacancies created by the resignations of Diane Levitan and Joseph Jasper, respectively. The board remains at six directors.
About the Company
PetVivo Holdings, Inc. (OTCQX: PETV), through subsidiaries PetVivo Animal Health, Inc., Somatrix Technologies, Inc. and PetVivo AI, Inc., develops, manufactures, commercializes and licenses medical devices, biomaterials and therapeutics for animal and human health.
About The Street Reports
The Street Reports (TSR) is a financial media awareness platform focused on emerging-growth, small-cap, micro-cap and nano-cap companies. The Street Reports publishes and distributes market-focused content across financial news, media and digital channels, providing companies with expanded visibility and exposure to a broad audience of readers and market participants.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media ContactCompany Name: The Street ReportsContact Person: EditorEmail: Send EmailCountry: United StatesWebsite: http://www.thestreetreports.com
